Calidi Biotherapeutics, Inc. - Common stock, par value $0.0001 per share (CLDI) Institutional Ownership

13F Institutional Holders and Ownership History from Q3 2025 to Q4 2025

Type / Class
Equity / Common stock, par value $0.0001 per share
Symbol
CLDI on NYSE
Shares outstanding
7,179,487
Price per share
$1.03
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
448,323
Total reported value
$524,682
% of total 13F portfolios
0%
Share change
+237,292
Value change
+$271,225
Number of holders
27
Price from insider filings
$1.03
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Calidi Biotherapeutics, Inc. - Common stock, par value $0.0001 per share (CLDI) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Gavrilov Ognian Anguelov 7.8% $659,792 560,000 Gavrilov Ognian Anguelov 20 Aug 2025
ARMISTICE CAPITAL, LLC 5% 117,368 Armistice Capital, LLC 30 Jun 2025

As of 31 Dec 2025, 27 institutional investors reported holding 448,323 shares of Calidi Biotherapeutics, Inc. - Common stock, par value $0.0001 per share (CLDI). This represents 6.2% of the company’s total 7,179,487 outstanding shares.

Institutional Holders of Calidi Biotherapeutics, Inc. - Common stock, par value $0.0001 per share (CLDI) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 448,323 $524,682 +$271,225 $1.17 27
2025 Q3 211,031 $320,773 +$320,773 $1.52 21